Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Amn Healthcare Services (AMN)

AMN Healthcare names Brian Scott CFO and COO as CFO Jeffrey Knudson departs

Neutral Impact 4 of 5 leadership Written later

AMN Healthcare appointed Brian Scott, its former CFO and Chief Accounting Officer from 2011 to 2021, as Chief Financial Officer and Chief Operating Officer, effective November 21, 2024. The appointment follows the announced departure of CFO Jeffrey Knudson, effective November 8, 2024, and places Scott in charge of finance and enterprise operating functions.

Key points

  • Brian Scott becomes CFO/COO on November 21, 2024, reporting to CEO Cary Grace.
  • Jeffrey Knudson leaves the CFO role effective November 8, 2024, to join a private company outside healthcare.
  • Scott's annualized base salary is $630,000, with a target bonus of 100% of base salary from 2025.
  • Scott receives a one-time equity grant valued at $2,000,000 on December 15, 2024, and a target 2025 LTIP award of $2,000,000.

The filing

CompanyAmn Healthcare Services (AMN)
Form8-K, current report
Filed with the SECOct 3, 2024, 4:54 PM ET
Accession number0000950142-24-002513

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:57 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 03, 2024.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.